VA/Nebraska/Western Iowa Health Care System
Omaha, Nebraska, 68105, United States
NCT Number: NCT00044434
The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients will receive either a time-released bupropion or placebo. Both groups will receive nicotine replacement therapy during the 9 week study. A final followup assessment will be conducted 6 months from the start of treatment.
Looking for future studies?
Notify Me25 year–75 year
All sexes
Interventional
Phase 4
Omaha, Nebraska, 68105, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00064844
Alcohol-Related Disorders, Alcoholism
Newington, Connecticut, United States
View Trial DetailsNCT01553136
Alcohol Abuse, Alcohol Drinking
New Haven, Connecticut, United States
View Trial DetailsNCT01414907
Alcohol-Related Disorders, Alcoholism
Malmö, Skåne County, Sweden
View Trial DetailsNCT00000437
Alcohol-Related Disorders, Alcoholism
Miami, Florida, United States
View Trial Details